首页 > 最新文献

中国现代神经疾病杂志最新文献

英文 中文
Clinical analysis of five cases of demyelinating pseudotumor 脱髓鞘性假瘤5例临床分析
Q4 Medicine Pub Date : 2017-03-25 DOI: 10.3969/CJCNN.V17I3.1566
Fu-rong Gu, Xiao-ling Yan, J. Qin, Xiao-lin Xu
Objective To study the clinical manifestations, imaging and pathological features, treatment and prognosis of 5 patients diagnosed as demyelinating pseudotumor (DPT) by pathology. Methods The data of clinical features, radiological and histological examination of 5 patients with DPT were retrospectively analyzed, and relevant literatures were reviewed. Results All patients were male. Main symptoms included limb weakness in 3 cases, dizziness and impaired memory in 2 cases, seizures in one case. Head MRI examination revealed space-occupying lesions with hypointense signal on T 1 WI, hyperintense signal on T 2 WI and FLAIR. Enhanced MRI showed obvious enhancement of lesions (open-ring enhancement in 3 cases). The lesion were totally (4 cases) or partially (one case) removed, and postoperative histological examination showed inflammatory demyelination. One case died after twice relapse, and others had favorable prognosis. Conclusions DPT is an inflammatory demyelination with mass effect. It should be differentiated from central nervous system tumors in order to avoid unnecessary resection or radiotherapy. DOI: 10.3969/j.issn.1672-6731.2017.03.010
目的探讨5例病理诊断为脱髓鞘性假瘤(DPT)的临床表现、影像学及病理特征、治疗及预后。方法回顾性分析5例DPT患者的临床表现、影像学及组织学检查资料,并复习相关文献。结果所有患者均为男性。主要症状为肢体无力3例,头晕、记忆障碍2例,癫痫发作1例。头部MRI示占位性病变,t1 WI呈低信号,t2 WI及FLAIR呈高信号。MRI增强显示病灶明显强化(3例开环强化)。病灶全部(4例)或部分(1例)切除,术后组织学检查示炎性脱髓鞘。2次复发1例死亡,其余预后良好。结论DPT是一种具有肿块效应的炎性脱髓鞘。应与中枢神经系统肿瘤鉴别,以避免不必要的切除或放疗。DOI: 10.3969 / j.issn.1672-6731.2017.03.010
{"title":"Clinical analysis of five cases of demyelinating pseudotumor","authors":"Fu-rong Gu, Xiao-ling Yan, J. Qin, Xiao-lin Xu","doi":"10.3969/CJCNN.V17I3.1566","DOIUrl":"https://doi.org/10.3969/CJCNN.V17I3.1566","url":null,"abstract":"Objective To study the clinical manifestations, imaging and pathological features, treatment and prognosis of 5 patients diagnosed as demyelinating pseudotumor (DPT) by pathology. Methods The data of clinical features, radiological and histological examination of 5 patients with DPT were retrospectively analyzed, and relevant literatures were reviewed. Results All patients were male. Main symptoms included limb weakness in 3 cases, dizziness and impaired memory in 2 cases, seizures in one case. Head MRI examination revealed space-occupying lesions with hypointense signal on T 1 WI, hyperintense signal on T 2 WI and FLAIR. Enhanced MRI showed obvious enhancement of lesions (open-ring enhancement in 3 cases). The lesion were totally (4 cases) or partially (one case) removed, and postoperative histological examination showed inflammatory demyelination. One case died after twice relapse, and others had favorable prognosis. Conclusions DPT is an inflammatory demyelination with mass effect. It should be differentiated from central nervous system tumors in order to avoid unnecessary resection or radiotherapy. DOI: 10.3969/j.issn.1672-6731.2017.03.010","PeriodicalId":10113,"journal":{"name":"中国现代神经疾病杂志","volume":"17 1","pages":"214-222"},"PeriodicalIF":0.0,"publicationDate":"2017-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46454002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Protective effect of nerve growth factor on glucocorticoid-induced apoptosis of primary cultured rat hippocampal neurons 神经生长因子对糖皮质激素诱导的大鼠海马神经元凋亡的保护作用
Q4 Medicine Pub Date : 2017-03-25 DOI: 10.3969/CJCNN.V17I3.1565
Yinghua Xia, Xiao-dong Kong, P. Lei, Shi-shuang Zhang, Ming-yi Zhang, Zilong Zhao, X. Ge
Objective To observe the protective effect of nerve growth factor (NGF) on apoptosis of primary cultured rat hippocampal neurons which were induced by glucocorticoids.  Methods The neurons isolated from the hippocampus of 18 neonatal Wister rats were cultured in vitro. Methyl thiazolyl tetrazolium (MTT) analysis was used to detect the lowest concentration of dexamethasone-induced hippocampal neuronal apoptosis, so as to explore the protective effect of different concentrations of NGF on 0.10 × 10 6 mol/L dexamethasone-induced hippocampal neuronal apoptosis.  Results Compared with negative control group, the activity of rat hippocampal neurons was reduced significantly in dexamethasone Ⅰ (10 × 10 6 mol/L), Ⅱ (1 × 10 6 mol/L) and Ⅲ (0.10 × 10 6 mol/L) groups ( P = 0.000, 0.000, 0.000). After different concentrations of NGF were given, the activity of hippocampal neurons in NGF 0.18 ng/ml group was significantly lower than negative control group ( P = 0.000) and positive control group ( P = 0.010), while the activity of hippocampal neurons in NGF 18 ng/ml group was significantly higher than positive control group ( P = 0.000) and NGF 0.18 ng/ml group ( P = 0.000). Conclusions Glucocorticoids can induce the apoptosis of in vitro cultured rat hippocampal neurons, and 0.10 × 10 6 mol/L dexamethasone is the lowest sensitive dose. NGF plays a role of blocking dexamethasone-induced apoptosis. DOI: 10.3969/j.issn.1672-6731.2017.03.009
目的观察神经生长因子(NGF)对糖皮质激素诱导的原代培养大鼠海马神经元凋亡的保护作用。方法对18只新生Wister大鼠海马分离神经元进行体外培养。采用甲基噻唑四氮唑(MTT)法检测地塞米松诱导海马神经元凋亡的最低浓度,探讨不同浓度NGF对地塞米松诱导的0.10 × 10 6 mol/L海马神经元凋亡的保护作用。结果与阴性对照组比较,地塞米松Ⅰ(10 × 10 6 mol/L)、Ⅱ(1 × 10 6 mol/L)和Ⅲ(0.10 × 10 6 mol/L)组大鼠海马神经元活性明显降低(P = 0.000、0.000、0.000)。不同浓度NGF给药后,NGF 0.18 ng/ml组海马神经元活性显著低于阴性对照组(P = 0.000)和阳性对照组(P = 0.010),而NGF 18 ng/ml组海马神经元活性显著高于阳性对照组(P = 0.000)和NGF 0.18 ng/ml组(P = 0.000)。结论糖皮质激素可诱导体外培养大鼠海马神经元凋亡,0.10 × 10 6 mol/L地塞米松为最低敏感剂量。NGF具有阻断地塞米松诱导的细胞凋亡的作用。DOI: 10.3969 / j.issn.1672-6731.2017.03.009
{"title":"Protective effect of nerve growth factor on glucocorticoid-induced apoptosis of primary cultured rat hippocampal neurons","authors":"Yinghua Xia, Xiao-dong Kong, P. Lei, Shi-shuang Zhang, Ming-yi Zhang, Zilong Zhao, X. Ge","doi":"10.3969/CJCNN.V17I3.1565","DOIUrl":"https://doi.org/10.3969/CJCNN.V17I3.1565","url":null,"abstract":"Objective To observe the protective effect of nerve growth factor (NGF) on apoptosis of primary cultured rat hippocampal neurons which were induced by glucocorticoids.  Methods The neurons isolated from the hippocampus of 18 neonatal Wister rats were cultured in vitro. Methyl thiazolyl tetrazolium (MTT) analysis was used to detect the lowest concentration of dexamethasone-induced hippocampal neuronal apoptosis, so as to explore the protective effect of different concentrations of NGF on 0.10 × 10 6 mol/L dexamethasone-induced hippocampal neuronal apoptosis.  Results Compared with negative control group, the activity of rat hippocampal neurons was reduced significantly in dexamethasone Ⅰ (10 × 10 6 mol/L), Ⅱ (1 × 10 6 mol/L) and Ⅲ (0.10 × 10 6 mol/L) groups ( P = 0.000, 0.000, 0.000). After different concentrations of NGF were given, the activity of hippocampal neurons in NGF 0.18 ng/ml group was significantly lower than negative control group ( P = 0.000) and positive control group ( P = 0.010), while the activity of hippocampal neurons in NGF 18 ng/ml group was significantly higher than positive control group ( P = 0.000) and NGF 0.18 ng/ml group ( P = 0.000). Conclusions Glucocorticoids can induce the apoptosis of in vitro cultured rat hippocampal neurons, and 0.10 × 10 6 mol/L dexamethasone is the lowest sensitive dose. NGF plays a role of blocking dexamethasone-induced apoptosis. DOI: 10.3969/j.issn.1672-6731.2017.03.009","PeriodicalId":10113,"journal":{"name":"中国现代神经疾病杂志","volume":"17 1","pages":"209-213"},"PeriodicalIF":0.0,"publicationDate":"2017-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41754445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical study on treating post-stroke sleep disorders by fastigial nucleus stimulation 颅顶核刺激治疗脑卒中后睡眠障碍的临床研究
Q4 Medicine Pub Date : 2017-03-25 DOI: 10.3969/cjcnn.v17i3.1562
Si-wei Liu, Min Guan, Bao-jin Li, Cheng Li, Q. Gao
Objective To discuss the efficacy and safety of fastigial nucleus stimulation (FNS) in the treatment of post-stroke sleep disorders (PSSD). Methods A total of 69 cases with PSSD were randomly divided into 3 groups: control group (N = 23), sham group (N = 23) and treatment group (N = 23). Control group received routine treatment, sham group received routine treatment plus sham FNS treatment, and treatment group received routine treatment plus FNS treatment. Pittsburgh Sleep Quality Index (PSQI) was used to evaluate the sleep quality of patients in 3 groups before and after 4-week treatment. Adverse reactions during the FNS treatment were also observed. Results There was statistical significance in PSQI scores among 3 groups before and after 4-week treatment ( P = 0.020). PSQI score after 4-week treatment in treatment group was significantly lower than control group and sham group ( P = 0.000, 0.000). Compared to before treatment, PSQI scores were significantly decreased in 3 groups after 4-week treatment ( P = 0.000). Conclusions FNS safely and effectively improves the sleep quality of patients with PSSD, thus it can be used as one of the auxiliary treatments for curing PSSD. DOI: 10.3969/j.issn.1672-6731.2017.03.006
目的探讨小脑顶核刺激(FNS)治疗脑卒中后睡眠障碍(PSSD)的疗效和安全性。方法将69例PSSD患者随机分为3组:对照组(N=23)、假手术组(N=23)和治疗组(N=2 3)。对照组常规治疗,假手术组常规治疗加假FNS治疗,治疗组常规治疗+FNS治疗。采用匹兹堡睡眠质量指数(PSQI)对3组患者治疗4周前后的睡眠质量进行评价。FNS治疗期间也观察到不良反应。结果3组治疗前后PSQI评分均有统计学意义(P=0.020),治疗组治疗4周后PSQI评分明显低于对照组和假手术组(P=0.000、0.000),结论FNS安全有效地改善了PSSD患者的睡眠质量,可作为治疗PSSD的辅助治疗方法之一。DOI:10.3969/j.issn.1672-6731017.03.006
{"title":"Clinical study on treating post-stroke sleep disorders by fastigial nucleus stimulation","authors":"Si-wei Liu, Min Guan, Bao-jin Li, Cheng Li, Q. Gao","doi":"10.3969/cjcnn.v17i3.1562","DOIUrl":"https://doi.org/10.3969/cjcnn.v17i3.1562","url":null,"abstract":"Objective To discuss the efficacy and safety of fastigial nucleus stimulation (FNS) in the treatment of post-stroke sleep disorders (PSSD). Methods A total of 69 cases with PSSD were randomly divided into 3 groups: control group (N = 23), sham group (N = 23) and treatment group (N = 23). Control group received routine treatment, sham group received routine treatment plus sham FNS treatment, and treatment group received routine treatment plus FNS treatment. Pittsburgh Sleep Quality Index (PSQI) was used to evaluate the sleep quality of patients in 3 groups before and after 4-week treatment. Adverse reactions during the FNS treatment were also observed. Results There was statistical significance in PSQI scores among 3 groups before and after 4-week treatment ( P = 0.020). PSQI score after 4-week treatment in treatment group was significantly lower than control group and sham group ( P = 0.000, 0.000). Compared to before treatment, PSQI scores were significantly decreased in 3 groups after 4-week treatment ( P = 0.000). Conclusions FNS safely and effectively improves the sleep quality of patients with PSSD, thus it can be used as one of the auxiliary treatments for curing PSSD. DOI: 10.3969/j.issn.1672-6731.2017.03.006","PeriodicalId":10113,"journal":{"name":"中国现代神经疾病杂志","volume":"17 1","pages":"192-196"},"PeriodicalIF":0.0,"publicationDate":"2017-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46818562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of motor relearning programme on motor function recovery of acute stroke patients with hemiplegia 运动再学习方案对急性脑卒中偏瘫患者运动功能恢复的影响
Q4 Medicine Pub Date : 2017-03-25 DOI: 10.3969/CJCNN.V17I3.1563
Min Guan, Si-wei Liu, Bao-jin Li, Cheng Li, Yun Qu
Objective To explore the effect of motor relearning programme (MRP) on motor function recovery of patients with hemiplegia after acute stroke.  Methods A total of 64 hemiplegic patients with acute stroke (duration ≤ 14 d) were randomly divided into 2 groups: control group (N = 32) and observation group (N = 32). Control group received routine drug therapy and conventional rehabilitation training, and observation group was treated by routine therapy and MRP training. Fugl-Meyer Assessment Scale - Balance (FMA - Balance), Modified Rivermead Mobility Index (MRMI) and modified Barthel Index (mBI) were used to assess the motor function of patients in both groups before and after treatment.  Results All patients successfully completed the rehabilitation training without severe adverse events. A few patients felt fatigue occasionally after training and recovered after rest. Compared to before treatment, the FMA-Balance score ( P = 0.000), MRMI score ( P = 0.000) and mBI score ( P = 0.000) after treatment in both groups were significantly increased. Compared to control group, the FMA-Balance score ( P = 0.031), MRMI score ( P = 0.013) and mBI score ( P = 0.049) after treatment in observation group were significantly increased.  Conclusions MRP training in the early stage of stroke is beneficial to the recovery of motor function of patients. DOI: 10.3969/j.issn.1672-6731.2017.03.007
目的探讨运动再学习计划(MRP)对急性脑卒中偏瘫患者运动功能恢复的影响。方法将64例急性脑卒中偏瘫患者(病程≤14d)随机分为2组:对照组(N=32)和观察组(N=32)。对照组采用常规药物治疗和常规康复训练,观察组采用常规治疗和MRP训练。采用Fugl-Meyer平衡评定量表(FMA-Balance)、改良Rivermead活动度指数(MRMI)和改良Barthel指数(mBI)对两组患者治疗前后的运动功能进行评定。结果所有患者均顺利完成康复训练,无严重不良事件发生。少数患者在训练后偶尔感到疲劳,休息后恢复。与治疗前相比,两组治疗后FMA Balance评分(P=0.000)、MRMI评分(P=0.0000)和mBI评分(P=0.00000)均显著升高。与对照组相比,观察组治疗后FMA-Balance评分(P=0.031)、MRMI评分(P=0.013)和mBI评分(P=0.049)显著升高。结论脑卒中早期MRP训练有利于患者运动功能的恢复。DOI:10.3969/j.issn.1672-6731017.03.007
{"title":"Effect of motor relearning programme on motor function recovery of acute stroke patients with hemiplegia","authors":"Min Guan, Si-wei Liu, Bao-jin Li, Cheng Li, Yun Qu","doi":"10.3969/CJCNN.V17I3.1563","DOIUrl":"https://doi.org/10.3969/CJCNN.V17I3.1563","url":null,"abstract":"Objective To explore the effect of motor relearning programme (MRP) on motor function recovery of patients with hemiplegia after acute stroke.  Methods A total of 64 hemiplegic patients with acute stroke (duration ≤ 14 d) were randomly divided into 2 groups: control group (N = 32) and observation group (N = 32). Control group received routine drug therapy and conventional rehabilitation training, and observation group was treated by routine therapy and MRP training. Fugl-Meyer Assessment Scale - Balance (FMA - Balance), Modified Rivermead Mobility Index (MRMI) and modified Barthel Index (mBI) were used to assess the motor function of patients in both groups before and after treatment.  Results All patients successfully completed the rehabilitation training without severe adverse events. A few patients felt fatigue occasionally after training and recovered after rest. Compared to before treatment, the FMA-Balance score ( P = 0.000), MRMI score ( P = 0.000) and mBI score ( P = 0.000) after treatment in both groups were significantly increased. Compared to control group, the FMA-Balance score ( P = 0.031), MRMI score ( P = 0.013) and mBI score ( P = 0.049) after treatment in observation group were significantly increased.  Conclusions MRP training in the early stage of stroke is beneficial to the recovery of motor function of patients. DOI: 10.3969/j.issn.1672-6731.2017.03.007","PeriodicalId":10113,"journal":{"name":"中国现代神经疾病杂志","volume":"17 1","pages":"197-201"},"PeriodicalIF":0.0,"publicationDate":"2017-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44836945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Mixed pleomorphic xanthoastrocytoma and ganglioglioma with existence of BRAF V600E mutation 存在BRAF V600E突变的混合型多形性黄色星形细胞瘤和神经节胶质瘤
Q4 Medicine Pub Date : 2017-03-25 DOI: 10.3969/cjcnn.v17i3.1564
Leiming Wang, Yong-juan Fu, Zhuo Li, Cui-cui Liu, D. Lu
Objective To investigate the clinicopathological and molecular genetic features of one case of mixed pleomorphic xanthoastrocytoma (PXA) and ganglioglioma (GG) with BRAF V600E mutation.  Methods and Results A 14-year-old boy mainly presented paroxymal loss of consciousness and tic of limbs for 6 years. Head MRI displayed circular abnormal signal on the hippocampus of left temporal lobe, considering space-occupying lesion. The patient underwent operation, and the lesion was totally removed. Pink gyri in deep temporal lobe could be seen during the operation. The tumor tissue was red grey, tough, nonencapsulated, with calcification, cystic degeneration, rich blood supply and clear boundary. Morphology showed the tumor grew diffusely and was heterogeneous: some areas showed the structure of GG and others showed the structure of PXA. Immunohistochemical staining and special staining showed in the region of GG, the tumor was scatteredly positive for glial fibrillary acidic protein (GFAP) and neurofilament protein (NF), gangliocyte-like cells were positive for microtubule associated protein-2 (MAP-2) and neuronal nuclei (NeuN), Ki-67 labeling index was 2%; in the region of PXA, spindle tumor cells were scatteredly positive for GFAP and NF, xanthomatoid cells were positive for CD163 and CD68, Ki-67 labeling index was 3%-5%, reticular fibers were abundant. Molecular detection showed that BRAF V600E mutation existed in both parts of the tumor. The patient was not treated by postoperative radiotherapy or chemotherapy. He took antiepileptic drugs (AEDs) orally [sodium valproate 1.20 g (twice a day) and levetiracetam 0.50 g (twice a day)] for one year, and the symptoms were greatly improved. He had no evidence of tumor recurrence in the 18-month follow-up period.  Conclusions Combined PXA and GG is a rare tumor of the central nervous system (CNS). The tumor showed different morphological features of PXA and GG, but with the same BRAF V600E mutation molecular characteristics. This case may support the study on morphology, histological origin and molecular genetics for PXA and GG. DOI: 10.3969/j.issn.1672-6731.2017.03.008
目的探讨1例BRAF V600E突变的混合型多形性黄色星形细胞瘤(PXA)和神经节胶质瘤(GG)的临床病理和分子遗传学特征。方法与结果一名14岁男孩,6年来主要表现为肢体意识丧失和抽搐。考虑到占位性病变,头部MRI显示左颞叶海马出现环状异常信号。患者接受了手术,病变被完全切除。术中可见颞叶深部粉红色回影。肿瘤组织呈红灰色,坚韧,无包膜,钙化,囊性变性,血供丰富,边界清晰。形态学显示肿瘤生长广泛且不均匀:部分区域显示GG结构,其他区域显示PXA结构。免疫组化染色和特异性染色显示GG区,胶质纤维酸性蛋白(GFAP)和神经丝蛋白(NF)呈散在阳性,神经节细胞样细胞微管相关蛋白2(MAP-2)和神经元细胞核(NeuN)呈阳性,Ki-67标记指数为2%;PXA区梭形瘤细胞GFAP和NF呈散在阳性,黄色瘤样细胞CD163和CD68呈阳性,Ki-67标记指数为3%-5%,网状纤维丰富。分子检测显示BRAF V600E突变存在于肿瘤的两个部位。患者未接受术后放疗或化疗。他口服抗癫痫药物(AEDs)[丙戊酸钠1.20克(每天两次)和左乙拉西坦0.50克(每天二次)]一年,症状大大改善。在18个月的随访期内,他没有肿瘤复发的证据。结论PXA和GG是一种罕见的中枢神经系统肿瘤。肿瘤表现出不同的PXA和GG形态特征,但具有相同的BRAF V600E突变分子特征。该病例可能支持PXA和GG的形态学、组织学起源和分子遗传学研究。DOI:10.3969/j.issn.1672-731.2017.03.008
{"title":"Mixed pleomorphic xanthoastrocytoma and ganglioglioma with existence of BRAF V600E mutation","authors":"Leiming Wang, Yong-juan Fu, Zhuo Li, Cui-cui Liu, D. Lu","doi":"10.3969/cjcnn.v17i3.1564","DOIUrl":"https://doi.org/10.3969/cjcnn.v17i3.1564","url":null,"abstract":"Objective To investigate the clinicopathological and molecular genetic features of one case of mixed pleomorphic xanthoastrocytoma (PXA) and ganglioglioma (GG) with BRAF V600E mutation.  Methods and Results A 14-year-old boy mainly presented paroxymal loss of consciousness and tic of limbs for 6 years. Head MRI displayed circular abnormal signal on the hippocampus of left temporal lobe, considering space-occupying lesion. The patient underwent operation, and the lesion was totally removed. Pink gyri in deep temporal lobe could be seen during the operation. The tumor tissue was red grey, tough, nonencapsulated, with calcification, cystic degeneration, rich blood supply and clear boundary. Morphology showed the tumor grew diffusely and was heterogeneous: some areas showed the structure of GG and others showed the structure of PXA. Immunohistochemical staining and special staining showed in the region of GG, the tumor was scatteredly positive for glial fibrillary acidic protein (GFAP) and neurofilament protein (NF), gangliocyte-like cells were positive for microtubule associated protein-2 (MAP-2) and neuronal nuclei (NeuN), Ki-67 labeling index was 2%; in the region of PXA, spindle tumor cells were scatteredly positive for GFAP and NF, xanthomatoid cells were positive for CD163 and CD68, Ki-67 labeling index was 3%-5%, reticular fibers were abundant. Molecular detection showed that BRAF V600E mutation existed in both parts of the tumor. The patient was not treated by postoperative radiotherapy or chemotherapy. He took antiepileptic drugs (AEDs) orally [sodium valproate 1.20 g (twice a day) and levetiracetam 0.50 g (twice a day)] for one year, and the symptoms were greatly improved. He had no evidence of tumor recurrence in the 18-month follow-up period.  Conclusions Combined PXA and GG is a rare tumor of the central nervous system (CNS). The tumor showed different morphological features of PXA and GG, but with the same BRAF V600E mutation molecular characteristics. This case may support the study on morphology, histological origin and molecular genetics for PXA and GG. DOI: 10.3969/j.issn.1672-6731.2017.03.008","PeriodicalId":10113,"journal":{"name":"中国现代神经疾病杂志","volume":"17 1","pages":"202-208"},"PeriodicalIF":0.0,"publicationDate":"2017-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41421729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Glasgow Coma Scale on the choice of treatment strategy in acute hypertensive intracerebral hemorrhage 格拉斯哥昏迷评分对急性高血压脑出血治疗策略选择的影响
Q4 Medicine Pub Date : 2017-03-25 DOI: 10.3969/CJCNN.V17I3.1568
Ning Zhang, Hua-tang Yang
Objective To investigate the effect of Glasgow Coma Scale (GCS) on the choice of treatment strategy in acute hypertensive intracerebral hemorrhage.  Methods Among 286 patients with hypertensive intracerebral hemorrhage, 186 patients underwent operation. According to GCS scores on admission, 186 cases included 94 cases of GCS 5-8, 71 cases of GCS 9-11 and 21 cases of GCS 12-14. These patients respectively underwent hematoma clearance and decompressive craniotomy (N = 63, 22.03%), hematoma clearance (N = 21, 7.34%), trepanation and drainage or external ventricular drainage (N = 102, 35.66%). The rest (N = 100) underwent conservative treatment, including 25 cases of GCS 5-8, 27 cases of GCS 9-11, 25 cases of GCS 12-14 and 23 cases of GCS 15. Glasgow Outcome Scale (GOS) was used to evaluate curative effect after 3-6 months follow-up.  Results The proportion of GOS in GCS 5-8 group was 14 cases (11.76%) of Grade 1, 21 cases (17.65%) of Grade 2, 39 cases (32.77%) of Grade 3, 22 cases (18.49%) of Grade 4 and 17 cases (14.29%) of Grade 5, except 6 lost cases (5.04%). The proportion of GOS in GCS 9-11 group was 6 cases (6.12%) of Grade 1, 2 cases (2.04%) of Grade 2, 6 cases (6.12%) of Grade 3, 48 cases (48.98%) of Grade 4 and 34 cases (34.69%) of Grade 5, except 2 lost cases (2.04%). The proportion of GOS in GCS 12-14 group was 15 cases (32.61%) of Grade 4 and 31 cases (67.39%) of Grade 5. The proportion of GOS in GCS 15 group was one case (4.35%) of Grade 4 and 22 cases (95.65%) of Grade 5. Differences between groups had statistical significance ( χ 2 = 142.966, P = 0.000). Conclusions The prognosis of patients with hypertensive intracerebral hemorrhage is positively related to GCS score on admission. The higher the GCS score is, the higher the GOS grade will be. DOI: 10.3969/j.issn.1672-6731.2017.03.011
目的探讨格拉斯哥昏迷量表(GCS)对急性高血压脑出血治疗策略选择的影响。方法286例高血压脑出血患者中,186例接受了手术治疗。根据入院时的GCS评分,186例包括GCS 5-8 94例、GCS 9-11 71例和GCS 12-14 21例。这些患者分别接受了血肿清除和减压开颅术(N=63,22.03%)、血肿清除术(N=21,7.34%)、钻孔引流或室外引流术(N=102,35.66%)。其余(N=100)接受了保守治疗,其中GCS5-8 25例,GCS9-11 27例,GCS12-14 25例和GCS15 23例。采用格拉斯哥预后量表(GOS)对随访3-6个月的疗效进行评价。结果GCS 5-8组GOS除6例丢失(5.04%)外,其余1级14例(11.76%),2级21例(17.65%),3级39例(32.77%),4级22例(18.49%),5级17例(14.29%),GCS 12-14组GOS比例为4级15例(32.61%),5级31例(67.39%)。GCS 15组GOS的比例为1例(4.35%)为4级,22例(95.65%)为5级。结论高血压脑出血患者的预后与入院时GCS评分呈正相关。GCS得分越高,GOS等级就越高。DOI:10.3969/j.issn.1672-67312017.03.011
{"title":"Effect of Glasgow Coma Scale on the choice of treatment strategy in acute hypertensive intracerebral hemorrhage","authors":"Ning Zhang, Hua-tang Yang","doi":"10.3969/CJCNN.V17I3.1568","DOIUrl":"https://doi.org/10.3969/CJCNN.V17I3.1568","url":null,"abstract":"Objective To investigate the effect of Glasgow Coma Scale (GCS) on the choice of treatment strategy in acute hypertensive intracerebral hemorrhage.  Methods Among 286 patients with hypertensive intracerebral hemorrhage, 186 patients underwent operation. According to GCS scores on admission, 186 cases included 94 cases of GCS 5-8, 71 cases of GCS 9-11 and 21 cases of GCS 12-14. These patients respectively underwent hematoma clearance and decompressive craniotomy (N = 63, 22.03%), hematoma clearance (N = 21, 7.34%), trepanation and drainage or external ventricular drainage (N = 102, 35.66%). The rest (N = 100) underwent conservative treatment, including 25 cases of GCS 5-8, 27 cases of GCS 9-11, 25 cases of GCS 12-14 and 23 cases of GCS 15. Glasgow Outcome Scale (GOS) was used to evaluate curative effect after 3-6 months follow-up.  Results The proportion of GOS in GCS 5-8 group was 14 cases (11.76%) of Grade 1, 21 cases (17.65%) of Grade 2, 39 cases (32.77%) of Grade 3, 22 cases (18.49%) of Grade 4 and 17 cases (14.29%) of Grade 5, except 6 lost cases (5.04%). The proportion of GOS in GCS 9-11 group was 6 cases (6.12%) of Grade 1, 2 cases (2.04%) of Grade 2, 6 cases (6.12%) of Grade 3, 48 cases (48.98%) of Grade 4 and 34 cases (34.69%) of Grade 5, except 2 lost cases (2.04%). The proportion of GOS in GCS 12-14 group was 15 cases (32.61%) of Grade 4 and 31 cases (67.39%) of Grade 5. The proportion of GOS in GCS 15 group was one case (4.35%) of Grade 4 and 22 cases (95.65%) of Grade 5. Differences between groups had statistical significance ( χ 2 = 142.966, P = 0.000). Conclusions The prognosis of patients with hypertensive intracerebral hemorrhage is positively related to GCS score on admission. The higher the GCS score is, the higher the GOS grade will be. DOI: 10.3969/j.issn.1672-6731.2017.03.011","PeriodicalId":10113,"journal":{"name":"中国现代神经疾病杂志","volume":"17 1","pages":"223-227"},"PeriodicalIF":0.0,"publicationDate":"2017-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42327763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Study on the causes and mechanism of atlantoaxial dislocation 寰枢关节脱位的病因及机制研究
Q4 Medicine Pub Date : 2017-03-25 DOI: 10.3969/CJCNN.V17I3.1569
Jing-wen Liu, Ju-ying Huang, F. Jian
Atlantoaxial joint, which is located in the body of the upper cervical spine, plays an important role in bearing and motion. It is the nerve center of medulla oblongata and spinal cord, and a lot of other important structures, such as neck arteriovenous and great occipital nerve, were distributed in this area, therefore the study on reasons and mechanism of atlantoaxial dislocation (AAD) is of great guiding significance for clinical treatment. This article will explore the specific mechanisms of AAD from the aspects of anatomy of atlantoaxial joint and surrounding structures, biomechanics and histology. DOI: 10.3969/j.issn.1672-6731.2017.03.012
寰枢椎关节位于上颈椎体部,在承载和运动中起着重要作用。它是延髓和脊髓的神经中枢,颈动静脉和枕大神经等许多重要结构也分布在该区域,因此研究寰枢椎脱位的原因和机制对临床治疗具有重要指导意义。本文将从寰枢椎关节及其周围结构的解剖学、生物力学和组织学等方面探讨AAD的具体机制。DOI:10.3969/j.issn.1672-6731017.03.012
{"title":"Study on the causes and mechanism of atlantoaxial dislocation","authors":"Jing-wen Liu, Ju-ying Huang, F. Jian","doi":"10.3969/CJCNN.V17I3.1569","DOIUrl":"https://doi.org/10.3969/CJCNN.V17I3.1569","url":null,"abstract":"Atlantoaxial joint, which is located in the body of the upper cervical spine, plays an important role in bearing and motion. It is the nerve center of medulla oblongata and spinal cord, and a lot of other important structures, such as neck arteriovenous and great occipital nerve, were distributed in this area, therefore the study on reasons and mechanism of atlantoaxial dislocation (AAD) is of great guiding significance for clinical treatment. This article will explore the specific mechanisms of AAD from the aspects of anatomy of atlantoaxial joint and surrounding structures, biomechanics and histology. DOI: 10.3969/j.issn.1672-6731.2017.03.012","PeriodicalId":10113,"journal":{"name":"中国现代神经疾病杂志","volume":"17 1","pages":"228-231"},"PeriodicalIF":0.0,"publicationDate":"2017-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46674046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical study of columnar balloon dilatation therapy for severe dysphagia caused by upper esophageal sphincter achalasia after stroke 柱状球囊扩张治疗脑卒中后上食管括约肌失弛缓症引起的严重吞咽困难的临床研究
Q4 Medicine Pub Date : 2017-03-25 DOI: 10.3969/CJCNN.V17I3.1561
Wei-bo Shao, Yaofei Wang, Wei Jiang, L. Tian, Jiehong Zhang
Objective To investigate the mechanism and effect of columnar balloon dilatation therapy on treating patients with severe dysphagia caused by upper esophageal sphincter (UES) achalasia after stroke. Methods Sixty -four patients with severe dysphagia caused by UES achalasia after stroke were diagnosed through Video Fluoroscopic Swallowing Study (VFSS) and esophageal dynamics testing. The patients were randomly divided into control group (N = 32) and treatment group (N = 32). Patients in control group were treated with routine drug treatment and routine rehabilitation training, while patients in treatment group were treated with columnar balloon dilatation therapy on the basis of routine treatment. The treatment end point was either the patient resuming an oral diet or after 4-weeks treatment. All cases were evaluated by swallowing function of VFSS, high resolution manometry (HRM) and scores of the severity of dysphagia before treatment and at treatment end point. Results Compared with before treatment, UES resting pressure ( P = 0.000) and residual pressure ( P = 0.000) were significantly decreased, peak pressure was significantly increased ( P = 0.000), duration of relaxation was prolonged ( P = 0.000), and scores of the severity of dysphagia were significantly increased ( P = 0.000, 0.000) in both groups after treatment. Compared with control group, UES resting pressure ( P = 0.001) and residual pressure ( P = 0.000) were significantly decreased, peak pressure was significantly increased ( P = 0.002), duration of relaxation was prolonged ( P = 0.000), and scores of the severity of dysphagia were significantly increased ( P = 0.000) in treatment group after treatment. Until the treatment end point or after 4-week treatment, the total effective rate in treatment group was significantly higher than that in control group [93.75% (30/32) vs. 81.25% (26/32); χ 2 = 4.010, P = 0.000]. Conclusions Columnar balloon dilatation therapy is effective for reducing the tension of upper esophageal sphincter and relieving spasm after stroke. It has obvious therapeutic effect on the upper esophageal sphincter achalasia. DOI: 10.3969/j.issn.1672-6731.2017.03.005
目的探讨柱状球囊扩张治疗脑卒中后上食管括约肌失弛缓症引起的严重吞咽困难的机制及疗效。方法对64例脑卒中后UES贲门失弛缓症引起的严重吞咽困难患者,通过视频荧光镜吞咽研究(VFSS)和食管动力学测试进行诊断。将患者随机分为对照组(N=32)和治疗组(N=32)。对照组采用常规药物治疗和常规康复训练,治疗组在常规治疗的基础上采用柱状球囊扩张治疗。治疗终点是患者恢复口服饮食或治疗4周后。所有病例在治疗前和治疗结束时通过VFSS的吞咽功能、高分辨率测压(HRM)和吞咽困难严重程度评分进行评估。结果与治疗前相比,两组治疗后UES静息压(P=0.000)和残余压(P=0.0000)均显著降低,峰值压显著升高(P=0.000。与对照组相比,治疗组治疗后UES静息压(P=0.001)和残余压(P=0.000)显著降低,峰值压显著升高(P=0.002),放松时间延长(P=0.0000),吞咽困难严重程度评分显著升高(P=0.000)。直至治疗结束或治疗4周后,治疗组总有效率明显高于对照组[93.75%(30/32)vs.81.25%(26/32);χ2=4.010,P=0.000]。对食管上括约肌失弛缓症有明显的治疗作用。DOI:10.3969/j.issn.1672-6731017.03.005
{"title":"Clinical study of columnar balloon dilatation therapy for severe dysphagia caused by upper esophageal sphincter achalasia after stroke","authors":"Wei-bo Shao, Yaofei Wang, Wei Jiang, L. Tian, Jiehong Zhang","doi":"10.3969/CJCNN.V17I3.1561","DOIUrl":"https://doi.org/10.3969/CJCNN.V17I3.1561","url":null,"abstract":"Objective To investigate the mechanism and effect of columnar balloon dilatation therapy on treating patients with severe dysphagia caused by upper esophageal sphincter (UES) achalasia after stroke. Methods Sixty -four patients with severe dysphagia caused by UES achalasia after stroke were diagnosed through Video Fluoroscopic Swallowing Study (VFSS) and esophageal dynamics testing. The patients were randomly divided into control group (N = 32) and treatment group (N = 32). Patients in control group were treated with routine drug treatment and routine rehabilitation training, while patients in treatment group were treated with columnar balloon dilatation therapy on the basis of routine treatment. The treatment end point was either the patient resuming an oral diet or after 4-weeks treatment. All cases were evaluated by swallowing function of VFSS, high resolution manometry (HRM) and scores of the severity of dysphagia before treatment and at treatment end point. Results Compared with before treatment, UES resting pressure ( P = 0.000) and residual pressure ( P = 0.000) were significantly decreased, peak pressure was significantly increased ( P = 0.000), duration of relaxation was prolonged ( P = 0.000), and scores of the severity of dysphagia were significantly increased ( P = 0.000, 0.000) in both groups after treatment. Compared with control group, UES resting pressure ( P = 0.001) and residual pressure ( P = 0.000) were significantly decreased, peak pressure was significantly increased ( P = 0.002), duration of relaxation was prolonged ( P = 0.000), and scores of the severity of dysphagia were significantly increased ( P = 0.000) in treatment group after treatment. Until the treatment end point or after 4-week treatment, the total effective rate in treatment group was significantly higher than that in control group [93.75% (30/32) vs. 81.25% (26/32); χ 2 = 4.010, P = 0.000]. Conclusions Columnar balloon dilatation therapy is effective for reducing the tension of upper esophageal sphincter and relieving spasm after stroke. It has obvious therapeutic effect on the upper esophageal sphincter achalasia. DOI: 10.3969/j.issn.1672-6731.2017.03.005","PeriodicalId":10113,"journal":{"name":"中国现代神经疾病杂志","volume":"17 1","pages":"185-191"},"PeriodicalIF":0.0,"publicationDate":"2017-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46234284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Study on early rehabilitation and rehabilitation technology after stroke: Chinese scholars' reports published abroad 脑卒中后早期康复及康复技术研究——国外中国学者报告
Q4 Medicine Pub Date : 2017-03-25 DOI: 10.3969/CJCNN.V17I3.1558
Wanjun Wang, Jia-Ling Wu
Stroke has become the second most common cause of death and the leading common cause of disability in China. Early rehabilitation of ischemic stroke has been approved widely, but early rehabilitation of hemorrhagic stroke has not been agreed, especially regard to the time for commence and the safety of early rehabilitation. Rehabilitation technology after stroke has been explored and researched continuously, in order to improve motor function and activities of daily living (ADL) of patients with stroke. This paper selected three high-quality perspective randomized controlled trails (RCTs) by Chinese scholars regarding early rehabilitation after stroke, which were published in foreign journals during past 3 years, and focused on study methods and results. DOI: 10.3969/j.issn.1672-6731.2017.03.002
中风已成为中国第二大常见死亡原因和第一大常见致残原因。缺血性脑卒中的早期康复已被广泛认可,但出血性脑卒中的早期康复尚未得到一致认可,特别是在早期康复的开始时间和安全性方面。脑卒中后康复技术不断被探索和研究,以改善脑卒中患者的运动功能和日常生活活动能力。本文选取近3年来发表在国外期刊上的3篇中国学者关于脑卒中后早期康复的高质量视角随机对照试验(RCTs),重点研究研究方法和结果。DOI: 10.3969 / j.issn.1672-6731.2017.03.002
{"title":"Study on early rehabilitation and rehabilitation technology after stroke: Chinese scholars' reports published abroad","authors":"Wanjun Wang, Jia-Ling Wu","doi":"10.3969/CJCNN.V17I3.1558","DOIUrl":"https://doi.org/10.3969/CJCNN.V17I3.1558","url":null,"abstract":"Stroke has become the second most common cause of death and the leading common cause of disability in China. Early rehabilitation of ischemic stroke has been approved widely, but early rehabilitation of hemorrhagic stroke has not been agreed, especially regard to the time for commence and the safety of early rehabilitation. Rehabilitation technology after stroke has been explored and researched continuously, in order to improve motor function and activities of daily living (ADL) of patients with stroke. This paper selected three high-quality perspective randomized controlled trails (RCTs) by Chinese scholars regarding early rehabilitation after stroke, which were published in foreign journals during past 3 years, and focused on study methods and results. DOI: 10.3969/j.issn.1672-6731.2017.03.002","PeriodicalId":10113,"journal":{"name":"中国现代神经疾病杂志","volume":"17 1","pages":"166-170"},"PeriodicalIF":0.0,"publicationDate":"2017-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45289758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Parkinsonism following ventriculoperitoneal shunt for treating hydrocephalus:clinical analysis on three cases 脑室腹腔分流术治疗脑积水后帕金森病3例临床分析
Q4 Medicine Pub Date : 2017-02-25 DOI: 10.3969/cjcnn.v17i2.1550
Sheng Li, Lin Wang, H. Guan, Jun-ji Wei, B. Peng, X. Wan
Objective To explore the clinical presentations, imaging features, probable pathogenesis and therapy of parkinsonism following ventriculoperitoneal shunt (VPS) in hydrocephalus. Methods and Results There were 3 cases of parkinsonism following VPS in hydrocephalus. Case 1 presented parkinsonism one month after the second ventricular shunt, which was not relieved by another VPS, and was then treated by levodopa and benserazide. Case 2 developed neck rigidity and bradykinesia 17 years after VPS. Symptoms worsened shortly after taking sulpiride and did not improved with sulpiride cessation. Bradykinesia and decreased speech occurred 5 months after VPS in Case 3, and parkinsonism aggravated rapidly on the following day after taking olanzapine. CT and/or MRI of 3 cases showed fluctuating change (enlarging-shrinking) of lateral ventricles. They were diagnosed as parkinsonism following VPS, and responded well to levodopa and benserazide. Conclusions Parkinsonism, a rare complication following VPS in hydrocephalus, may result from interruption of nigrostriatal pathways due to ventricular fluctuations. Administration of dopamine D2 receptor antagonist may exacerbate the symptoms of parkinsonism because of "double hit". Most patients are responsive to dopaminergic drugs. DOI: 10.3969/j.issn.1672-6731.2017.02.008
目的探讨脑积水脑室-腹腔分流术后帕金森综合征的临床表现、影像学特点、可能的发病机制和治疗方法。方法与结果3例脑积水VPS并发帕金森综合征。病例1在第二次心室分流术后一个月出现帕金森综合征,但另一次VPS并未缓解,随后接受左旋多巴和苯塞拉齐治疗。病例2在VPS后17年出现颈部强直和运动迟缓。服用舒必利后不久症状恶化,停药后症状没有改善。病例3在VPS后5个月出现低血压和言语下降,服用奥氮平后第二天帕金森病迅速加重。3例CT和/或MRI显示侧脑室波动性改变(扩大缩小)。他们在VPS后被诊断为帕金森病,对左旋多巴和苯塞拉齐反应良好。结论帕金森病是脑积水VPS后一种罕见的并发症,可能是由于心室波动导致黑质纹状体通路中断所致。多巴胺D2受体拮抗剂的使用可能会因“双重打击”而加重帕金森综合征的症状。大多数患者对多巴胺能药物有反应。DOI:10.3969/j.issn.1672-6731017.02.008
{"title":"Parkinsonism following ventriculoperitoneal shunt for treating hydrocephalus:clinical analysis on three cases","authors":"Sheng Li, Lin Wang, H. Guan, Jun-ji Wei, B. Peng, X. Wan","doi":"10.3969/cjcnn.v17i2.1550","DOIUrl":"https://doi.org/10.3969/cjcnn.v17i2.1550","url":null,"abstract":"Objective To explore the clinical presentations, imaging features, probable pathogenesis and therapy of parkinsonism following ventriculoperitoneal shunt (VPS) in hydrocephalus. Methods and Results There were 3 cases of parkinsonism following VPS in hydrocephalus. Case 1 presented parkinsonism one month after the second ventricular shunt, which was not relieved by another VPS, and was then treated by levodopa and benserazide. Case 2 developed neck rigidity and bradykinesia 17 years after VPS. Symptoms worsened shortly after taking sulpiride and did not improved with sulpiride cessation. Bradykinesia and decreased speech occurred 5 months after VPS in Case 3, and parkinsonism aggravated rapidly on the following day after taking olanzapine. CT and/or MRI of 3 cases showed fluctuating change (enlarging-shrinking) of lateral ventricles. They were diagnosed as parkinsonism following VPS, and responded well to levodopa and benserazide. Conclusions Parkinsonism, a rare complication following VPS in hydrocephalus, may result from interruption of nigrostriatal pathways due to ventricular fluctuations. Administration of dopamine D2 receptor antagonist may exacerbate the symptoms of parkinsonism because of \"double hit\". Most patients are responsive to dopaminergic drugs. DOI: 10.3969/j.issn.1672-6731.2017.02.008","PeriodicalId":10113,"journal":{"name":"中国现代神经疾病杂志","volume":"17 1","pages":"127-132"},"PeriodicalIF":0.0,"publicationDate":"2017-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47116755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
中国现代神经疾病杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1